Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11657679 | 0.94 | ALDH1A1 (0.39) | ALOX15ALDH1A1TAAR1SMN1; SMN2 | |
| SCHEMBL9384271 | 0.94 | ALDH1A1 (0.39) | ALOX15ALDH1A1TAAR1SMN1; SMN2 | |
| SCHEMBL4018505 | 0.81 | — | — | |
| SCHEMBL3946326 | 0.79 | ALOX15 (0.36) | ALOX15ALDH1A1SMN1; SMN2 | |
| SCHEMBL9848964 | 0.79 | ALOX15 (0.36) | ALOX15ALDH1A1SMN1; SMN2 | |
| SCHEMBL2301191 | 0.79 | ALOX15 (0.36) | ALOX15ALDH1A1SMN1; SMN2 | |
| SCHEMBL18754403 | 0.77 | — | — | |
| SCHEMBL8083435 | 0.77 | — | — | |
| SCHEMBL6159550 | 0.77 | — | — | |
| SCHEMBL3946063 | 0.76 | ALDH1A1 (0.34) | ALOX15ALDH1A1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1256336-B1 | Two-phase gel composition | PENRECO (US) | 2016-10-19 | — | — | EP | disclosed |
| US-9339446-B2 | Gel composition | CALUMET PENRECO, LLC (US) | 2016-05-17 | — | — | US | disclosed |
| US-8771718-B2 | Formulated tick and insect repellent compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-07-08 | — | — | US | disclosed |
| EP-2094650-B1 | USE OF CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | MANE FILS V (FR) | 2011-09-21 | — | — | EP | disclosed |
| EP-2337544-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | Living Proof, Inc. (US) | 2011-06-29 | — | — | EP | disclosed |
| US-20110045983-A1 | Gel composition | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2011-02-24 | — | — | US | disclosed |
| US-20090232753-A1 | Gel compositions | HEALY LIN LU | 2009-09-17 | — | — | US | disclosed |
| EP-2094650-A1 | USE OF CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | V. Mane Fils (FR) | 2009-09-02 | — | — | EP | disclosed |
| EP-2040555-A2 | FORMULATED TICK AND INSECT REPELLENT COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-04-01 | — | — | EP | disclosed |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. | 2009-03-12 | — | — | US | disclosed |
| WO-2007133683-A2 | FORMULATED TICK AND INSECT REPELLENT COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-22 | — | — | WO | disclosed |
| US-20070264297-A1 | Formulated tick and insect repellent compositions | 1,4Group, Inc. | 2007-11-15 | — | — | US | disclosed |
| EP-1141111-B1 | GEL COMPOSITIONS | PENRECO (US) | 2005-08-03 | — | — | EP | disclosed |
| US-6881776-B2 | Gel compositions | PENRECO (US) | 2005-04-19 | — | — | US | disclosed |
| US-20050004274-A1 | Gel compositions | HEALY LIN LU (US) | 2005-01-06 | — | — | US | disclosed |
| EP-1256336-A2 | Two-phase gel composition | Penreco (US) | 2002-11-13 | — | — | EP | disclosed |
| US-20020055562-A1 | Gel compositions | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2002-05-09 | — | — | US | disclosed |
| EP-0838451-B1 | PROCESS FOR PRODUCING UNSATURATED ALCOHOLS | KAO CORP (JP) | 2001-11-28 | — | — | EP | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | MMP1, MMP9, MMP17 | ALOX15 798/4885ALDH1A1 2338/4885TAAR1 3058/4885 |
| US-20110045983-A1 | Gel composition | PGR, COPE, PTGER1 | ALOX15 757/4885ALDH1A1 3560/4885TAAR1 1036/4885 |
| US-20070264297-A1 | Formulated tick and insect repellent compositions | MME, FNTA, ACHE | ALOX15 3460/4885ALDH1A1 3113/4885TAAR1 556/4885 |
| US-20090232753-A1 | Gel compositions | PGR, COPE, PTGER1 | ALOX15 791/4885ALDH1A1 3505/4885TAAR1 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.